LGND - Jazz Pharma wins EU approval for blood cancer therapy
2023-09-22 09:29:56 ET
More on Jazz Pharma
- Seeking Alpha’s Quant Rating on Jazz Pharmaceuticals
- Historical earnings data for Jazz Pharmaceuticals
- Financial information for Jazz Pharmaceuticals
- Jazz Pharmaceuticals: Depressed Valuation Opens Up Potential
- Jazz Pharmaceuticals: Xywav Debate Continued Drag On Equity Performance
For further details see:
Jazz Pharma wins EU approval for blood cancer therapy